This HP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

• Wolfe Research analyst Andy Chen downgraded the rating for Celldex Therapeutics, Inc. CLDX from Outperform to Peer Perform. Celldex Therapeutics shares fell 8.7% to close at $32.86 on Thursday. See how other analysts view this stock.
• Keybanc analyst Justin Patterson downgraded Bumble Inc. BMBL from Overweight to Sector Weight. Bumble shares gained 1.9% to close at $6.44 on Thursday. See how other analysts view this stock.
• B of A Securities analyst Wamsi Mohan downgraded the rating for HP Inc. HPQ from Buy to Neutral and maintained the price target of $37. HP shares gained 2.2% to close at $36.85 on Thursday. See how other analysts view this stock.
• Leerink Partners analyst Andrew Berens downgraded Agios Pharmaceuticals, Inc. AGIO from Outperform to Market Perform while cutting the price target from $60 to $56. Agios Pharmaceuticals shares fell 2% to close at $48.05 on Thursday. See how other analysts view this stock.
• Morgan Stanley analyst Josh Baer downgraded the rating for Udemy, Inc. UDMY from Equal-Weight to Underweight and slashed the price target from $10 to $7.5. Udemy shares gained 1.3% to close at $8.13 on Thursday. See how other analysts view this stock.

Considering buying HP stock? Here’s what analysts think:

Read Next:

• Top 3 Real Estate Stocks That Are Preparing To Pump This Month